2/22/2013

Laboratory Corporation of America has invested $2 million in SynapDx. The Lexington, Mass.-based company will use the funding to develop a blood-based assay that can diagnose autism spectrum disorder in children earlier than existing tests.

Full Story:
Boston Herald

Related Summaries